The liver is a common site for metastatic spread for various primary tumor histologies.
Stereotactic body radiation therapy (SBRT) is a non-invasive treatment technique with broad …

Although resection is the standard of care for liver metastasis, 80–90% of patients are not
resectable at diagnosis. Advances in combination chemotherapy, particularly with targeted …

The utilization of stereotactic body radiation therapy for the treatment of liver metastasis has
been widely studied and has demonstrated favorable local control outcomes. However …

As an accurate external beam irradiation method, stereotactic body radiotherapy (SBRT) has
been increasingly used to deliver high dose in less fractions. The liver is one of the most …

For over half a century, conventionally fractionated whole-liver radiation has been used for
the palliation of diffuse, symptomatic liver metastases. More recently, interest has grown in …

Purpose To evaluate feasibility and efficacy of Stereotactic Body Radiation Therapy (SBRT)
for unresectable liver metastasis in oligometastatic patients. Methods Oligometastatic …

The management of hepatic malignancies presents several unique challenges to providers.
Surgical resection is the standard of care, but less than 30% of tumors are amenable to …

Background Stereotactic body radiation therapy (SBRT) is a safe and effective option for
treatment of liver metastases. However, existing data are mostly reported by high-volume …

Liver metastases occur commonly in many solid malignancies. With advances in systemic
therapies and increased life expectancy, the role of using local therapies in oligo …

PURPOSE: To evaluate the feasibility of high-dose stereotactic body radiation therapy
(SBRT) in the treatment of unresectable liver metastases. METHODS AND MATERIALS …